Abstract
Altered expressions of the key enzymes in arachidonic acid (AA) metabolism, prostaglandin synthase 1 and 2 and cysteinyl leukotriene C4 synthase, are of importance in understanding aspirin-induced asthma. We propose a mathematical model of AA metabolism and its interaction with non-steroidal anti-inflammatory drugs (NSAIDs). Model simulations depict the impact of modified expressions of the above enzymes on the time dependent synthesis of cysteinyl leukotrienes and anti-inflammatory prostaglandins before and during NSAID exposure in different model states describing healthy humans as well as aspirin-tolerant and -intolerant asthmatics. The results are compared and evaluated with experimental data taken from the literature. Our results identify the decreased expression of prostaglandin H synthase 1 and increased expression of leukotriene C4 synthase as the key elements in AA metabolism that contribute to increased leukotriene C4 and decreased anti-inflammatory prostaglandins after NSAID dosing in aspirin-intolerant patients. On the other hand, the decreased expression of prostaglandin H synthase 2 implies permanently increased leukotriene C4 and lowers the sensitivity to increased drug doses. The model is used for identification of susceptible patient populations for aspirin and ibuprofen, and for identification of critical aspirin doses that might induce bronchoconstriction.
Similar content being viewed by others
References
Szczeklik A, Stevenson D (1999) Aspirin-induced asthma: advances in pathogenesis and management. J Allergy Clin Immunol 104:5–13
Babu KS, Salvi SS (2000) Aspirin and asthma. Chest 118:1470–1476
Stevenson D, Szczeklik A (2006) Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol 118:773–786
Vane J, Botting R (1987) Inflammation and the mechanism of action of anti-inflammatory drugs. FASEB J 1:89–96
Drazen JM (1998) Leukotrienes as mediators of airway obstruction. Am J Respir Crit Care Med 158:193–200
Barnes NC, Smith LJ (1999) Biochemistry and physiology of the leukotrienes. Clin Rev Allergy Immunol 17:27–42
Setoguchi H, Nishimura J, Hirano K, Takahashi S, Kanaide H (2001) Leukotriene C4 enhances the contraction of porcine tracheal smooth muscle trough the activation of Y-27632, a rho kinase inhibitor, sensitive pathway. Br J Pharmacol 132:111–118
Bogatcheva N, Sergeeva M, Dudek S, Verin A (2005) Arachidonic acid cascade in endothelial pathobiology. Microvasc Res 69:107–127
Meade E, Smith W, DeWitt D (1993) Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 268:6610–6614
Gonchar M, Sergeeva M, Mevkh A, Varfolomeyev S (1999) Kinetics of prostanoid synthesis by macrophages is regulated by arachidonic acid sources. Eur J Biochem 265:779–787
So O-Y, Scarafia LE, Mak AY, Callan OH, Swinney DC (1998) The dynamics of prostaglandin H synthases. Study with prostaglandin H-synthase 2 Y355F unmask mechanisms of time-dependent inhibition and allosteric activation. J Biol Chem 273:5801–5807
Kanamoto H, Takemura M, Ohyama K (2009) Detection of 5-lipoxygenase activity in the liwerwort Marchantia polymorpha L. Biosci Biotechnol Biochem 73:2549–2551
Gupta N, Gresser M, Ford-Hutchinson A (1998) Kinetic mechanism of glutathione conjugation to leukotriene A4 by leukotriene C4 synthase. Biochim Biophys Acta 1391:157–168
Harizi H, Juzan M, Moreau J-F, Gualde N (2003) Prostaglandins inhibit 5-lipoxygenase-activating protein expression and leukotriene B4 production from dendritic cells via an IL-10-dependent mechanism. J Immunol 170:139–146
Callan OH, So O-Y, Swinney DC (1996) The kinetic factors that determine the affinity and selectivity for slow binding inhibition of human prostaglandin H synthase 1 and 2 by indomethacin and flurbiprofen. J Biol Chem 271:3548–3554
Cowburn AS, Sladek K, Soja A, Adamek L, Nizankowska E, Szczeklik A, Lam BK, Penrose J, Austen KF, Holgate ST, Sampson AP (1998) Over-expression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest 101:834–846
Pierzchalska M, Szabo Z, Sanak M, Soja J, Szczeklik A (2003) Deficient prostaglandin E2 production by bronchial fibroblasts of asthmatic patients, with special reference to aspirin induced asthma. J Allergy Clin Immunol 111:1041–1048
Schäfer D, Schmid M, Göde UC, Baenkler H-W (1999) Dynamics of eicosanoids in peripheral blood cells during provocation in aspirin-intolerant asthmatics. Eur Respir J 13:638–646
Picado C, Fernandez-Morata JC, Juan M, Roca-Ferrer J, Fuentes M, Xaubet A, Mullol J (1999) Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics. Am J Respir Crit Care Med 160:291–296
Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR (1994) Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 90:11693–11697
Aharony D, Stein R (1986) Kinetic mechanism of guinea pig neutrophil 5-lipoxygenase. J Biol Chem 261:11512–11519
Noguchi M, Miyano M, Kuhara S, Matsumoto T, Noma M (1994) Interfacial kinetic reaction of human 5-lipoxygenase. Eur J Biochem 222:285–292
Owen WF Jr, Soberman RJ, Yoshimoto T, Sheffer AL, Lewis RA, Austen KF (1987) Synthesis and release of leukotriene C4 by human eosinophils. J Immunol 138:532–538
Haeggström J, Bergman T, Jörnvall H, Rådmark O (1988) Guinea-pig liver leukotriene A4 hydrolase. Purification, characterization and structural properties. Eur J Biochem 174:717–724
Lam BK, Gagnon L, Austen KF, Soberman RJ (1990) The mechanism of leukotriene B4 export from human polymorphonuclear leukocytes. J Biol Chem 265:13438–13441
Rowland M, Riegelman S, Harris PA, Sholkof SD (1972) Absorption kinetics of aspirin in man following oral administration of an aqueous solution. J Pharm Sci 61:379–385
Klueglich M, Ring A, Scheuerer S, Trommeshauser D, Schuijt C, Liepold B, Berndl G (2005) Ibuprofen extrudate, a novel, rapidly dissolving ibuprofen formulation: relative bioavailability compared to ibuprofen lysinate and regular ibuprofen, and food effect on all formulations. J Clin Pharmacol 45:1055–1061
Täuber U, Brudny–Klöppel M, Jakobs U, Madetzki C, Mahler M (1993) Pharmacokinetics of nocloprost in human volunteers and its relation to dose. Eur J Clin Pharmacol 44:497–500
Acknowledgements
The authors acknowledge financial support from the state budget by the Slovenian Research Agency (Program No. P1-0055).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Dobovišek, A., Fajmut, A. & Brumen, M. Role of expression of prostaglandin synthases 1 and 2 and leukotriene C4 synthase in aspirin-intolerant asthma: a theoretical study. J Pharmacokinet Pharmacodyn 38, 261–278 (2011). https://doi.org/10.1007/s10928-011-9192-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10928-011-9192-6